Flecainide Acetate Tablets / 100 mg / 100 Count

Flecainide Acetate Tablets

100 mg / 100 Count
Back to Products

Brand name: Tambocor®

In patients without structural heart disease, flecainide acetate tablets, USP are indicated for the prevention of

– paroxysmal supraventricular tachycardias (PSVT), including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia and other supraventricular tachycardias of unspecified mechanism associated with disabling symptoms

– paroxysmal atrial fibrillation/flutter (PAF) associated with disabling symptoms
Flecainide acetate tablets, USP are also indicated for the prevention of

– documented ventricular arrhythmias, such as sustained ventricular tachycardia (sustained VT), that in the judgment of the physician are life-threatening.

Use of flecainide acetate tablets, USP for the treatment of sustained VT, like other antiarrhythmics, should be initiated in the hospital. The use of flecainide acetate tablets, USP are not recommended in patients with less severe ventricular arrhythmias even if the patients are symptomatic.

Because of the proarrhythmic effects of flecainide acetate tablets, USP, its use should be reserved for patients in whom, in the opinion of the physician, the benefits of treatment outweigh the risks.

Flecainide acetate tablets, USP should not be used in patients with recent myocardial infarction. (See BOXED WARNINGS.)

Use of flecainide acetate tablets, USP in chronic atrial fibrillation has not been adequately studied and is not recommended. (See BOXED WARNINGS.)

As is the case for other antiarrhythmic agents, there is no evidence from controlled trials that the use of flecainide acetate tablets, USP favorably affects survival or the incidence of sudden death.

For more information please see the prescribing information.

For more information please see the prescribing information on DailyMed.

Product Information
Product Name Flecainide Acetate Tablets
Strength 100 mg
Strength 100 mg
Dosage Form Tablets
Pack Size 100 Count
NDC 57237-064-01
OTC/Rx Rx
TE Code AB
Product Characteristics
Color White (White to Off-white)
Shape Round, Biconvex Tablets
Gluten Free from Gluten
Lactose Free from Lactose
Sweeteners Free from Sweeteners
Soy Free from Soy
Gelatin Free from Gelatin
Allergen Info Free from Egg, Nuts, Soy Protein
Other Product Info Free from Animal Products
Other Information
Inactive Ingredients

Croscarmellose sodium, hydrogenated cottonseed oil, magnesium stearate, cellulose, microcrystalline, starch, corn.

Imprint/Markings 1;2;CC
Special Instructions

Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature] in a tight, light-resistant container.

Product Shelf Life 24 months

*The brand names listed are not owned by Rising Pharma. Rising Pharma products are generic equivalents to the respective brand names listed on this website.